BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Announces Target Price $307
Looking Into Alnylam Pharmaceuticals's Recent Short Interest
Alnylam to Webcast TTR Investor Day
China Merchants Initiates Alnylam Pharmaceuticals at Buy With $360 Price Target
Alnylam Pharma Confident in ATTR-CM Treatment's Market Potential, Cautious on Regulatory Risks, RBC Says
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating
TD Cowen Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $282
TD Cowen Sticks to Their Buy Rating for Alnylam Pharma (ALNY)
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Trading At A 49% Discount?
The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- WSJ
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 10 Years
Alnylam Pharmaceuticals Analyst Ratings
Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now?
US MOVERS&SHAKERS Sep 02-Sep 06, 2024
Evercore Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $260
RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300
Express News | RBC Capital Reiterates Outperform on Alnylam Pharmaceuticals, Maintains $300 Price Target
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $307
A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $275 to $400
Alnylam Pharmaceuticals Is Maintained at Buy by B of A Securities